Sanger Institute Sequences 240 Pneumococcal Isolates to Track Evolution of Drug Resistance
February 08, 2011
Sanger Institute Sequences 240 Pneumococcal Isolates to Track Evolution of Drug Resistance
The study highlights the potential of next-generation sequencing to identify variants that allow pathogenic bacteria to evade drugs, and could enable the development of new therapies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Next-Gen Sequencing Helps Uncover Cause of TB Outbreak, Piece Together Transmission Patterns
March 1, 2011 / In Sequence - New Genomes Serve as Source of Information on Turtle Evolution, Adaptation
April 29, 2013 / GenomeWeb Daily News - Sequencing Study Yields Clues to Invasive Salmonella Emergence, Spread in Sub-Saharan Africa
October 1, 2012 / GenomeWeb Daily News - UK Hospitals Employ Rapid Sequencing on MiSeq to Monitor Outbreaks
June 20, 2012 / Clinical Sequencing News - Researchers Demonstrate WGS Potential for Tracking MRSA Outbreaks
June 14, 2012 / GenomeWeb Daily News